Our research group has also developed an SPRi-based analyticalplatform for the determination of erythropoietin (EPO) in biologicalfluids. EPO regulates erythroid precursorcell proliferation and serves as a therapeutic agent in various disorders.Moreover, elevated EPO activity has been observed in Alzheimer’sdisease (AD). This evidence concerns the gene EPO and Alzheimer disease.